Enzyme is restoring the Endolysin 'ability to destroy antibiotics, resistant bacteria. The scientists of the Karolinskay Institute have reached this conclusion. The results of the study were published in Nature magazine.
During the experiment, scientists injected mice injected resistant pneumonia that cause inflammation of the cerebral. After that, the rodents were given to Penicille, together with Andolysin, which is an enzyme that destroys the bacterial cell wall. This combination has restored antibiotic, the ability to destroy the pathogens. All experimental mice recovered without symptoms of disease.
According to the study, the Associate Professor of Medical Microbiology Federico Iovin, Endolysin penetrated his brain for several hours.
"The high speed of the enzyme opens new prospects for the treatment of the contagious inflammation of meningitis, brain and spinal cord," explained the researcher.
At the same time, according to the scientist, therapy must begin within two days of infection. If treatment is delayed, the risk of neurological complications and death increases.
Stability to antibiotics is already called "silent closet". The number of stable bacteria towards existing drugs is constantly growing. This complicates the treatment of severe infections, including pneumonia and meningitis. According to Iovov, 20-30 years later, stable bacteria will be the main reason for death, "exceeding" the number of cancer deaths.
Translation of: Euromedia24.com
